What researchers published on Mielóma multiplex
24 549 papers, newest first.
Showing 100 of 24 549
Carfilzomib-based strategies in transplant-eligible multiple myeloma: long-term follow-up of the phase 2 FORTE trial.Blood
ÁttekintésMacrophage Immunometabolic Reprogramming in Multiple Myeloma: Linking Spatial Niches to Therapy Resistance.Immunological investigations
A real-time text-based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study.British journal of haematology
Prognostic value of neutrophil-to-lymphocyte ratio among patients suffering from multiple myeloma: A systematic review and meta-analysis.Therapeutic advances in hematology
Etentamig in Relapsed/Refractory Multiple Myeloma: Pooled Phase 1 Data of an Investigational BCMA Bispecific Antibody.Blood
ÁttekintésNovel insights into the bone microenvironment in myeloma bone disease.Journal of bone oncology
EsetismertetésDetection of Urinary Round Cells in a Dog With IgA Paraproteinemia: A Case of Myeloma-Related Disorder.Veterinary clinical pathology
ÁttekintésEarly-line immunotherapy in multiple myeloma: reshaping the treatment paradigm.Frontiers in immunology
EsetismertetésIntegrated Genomic Characterization of Aggressive Multiple Myeloma With 1q21 Gain Reveals IL6R-Associated Chromatin Remodeling: A Case Report.Cancer reports (Hoboken, N.J.)
Ocular comorbidities are common in multiple myeloma: results of a large cross-sectional survey.The oncologist
EsetismertetésMultiple myeloma presenting with cavernous sinus syndrome: A case report and literature review.SAGE open medical case reports
Phase 3 trial data point to more options for patients with relapsed or refractory multiple myeloma: Teclistamab- and mezigdomide-based regimens could expand treatment options, set new standards of care, and improve survival.Cancer
EsetismertetésDiffuse abdominal calcifications in a patient with multiple myeloma and AL amyloidosis.The American journal of medicine
Treatment Patterns, Treatment Response, and Survival Outcomes in Patients with Multiple Myeloma: A Single-Center Real-World Study.Journal of clinical medicine
FedMann: A Manually Coordinated Federated Learning Framework Applied to Multiple Myeloma-A Feasibility Study.Journal of clinical medicine
Lower Dexamethasone Dose in Multiple Myeloma: A Multicenter Retrospective Analysis.Cancers
ÁttekintésMultiple Myeloma Measurable Residual Disease: Spotting Three Different Detection Methods.International journal of molecular sciences
ÁttekintésApproach to Patients with Multiple Myeloma after BCMA targeted Therapy.Current hematologic malignancy reports
Infectious complications after anti-BCMA CAR-T cell therapy in patients with multiple myeloma: a systematic literature review.Antimicrobial stewardship & healthcare epidemiology : ASHE
Megfigyeléses vizsgálatNutritional Risk, Weight Loss, and Inflammatory Profiles During Autologous Stem Cell Transplantation: Clinical Correlates in Patients with Lymphoma and Multiple Myeloma.Nutrients
ÁttekintésAchievement and Persistence of MRD Negativity with Anti-CD38-Based Regimens in Newly Diagnosed Multiple Myeloma: A Systematic Review and Network Meta-Analysis.Cancers
ÁttekintésThree-dimensional models of the multiple myeloma bone microenvironment: from disease mechanisms to translational applications.Frontiers in cell and developmental biology
Early Treatment Failure in Patients With Relapsed/Refractory Multiple Myeloma Receiving Bispecific T-Cell Engagers: Development and Validation of the CHARGE Prognostic Index.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Impact of residual clonal plasma cell proliferation rate after autologous stem cell transplant on outcomes in multiple myeloma.Blood cancer journal
Metabolic targeting of multiple myeloma using the Warburg Trap.Cancer cell international
Successful long-term management of severe psoriasis with secukinumab after autologous hematopoietic stem cell transplantation for multiple myeloma: a case report.Anais brasileiros de dermatologia
Szisztematikus áttekintésProgressive multifocal leukoencephalopathy, bispecific antibodies, and multiple myeloma: a case report and systematic review of the literature.Frontiers in oncology
Enhancing clinical teaching in hematology: a retrospective study on the integration of the PDCA cycle with case-based learning.BMC medical education
Teclistamab in multiple myeloma with coexisting myelodysplastic syndrome or acute myeloid leukemia.Haematologica
EsetismertetésHemiarthroplasty with a long femoral stem and proximal cement augmentation for a myeloma-related pathological femoral neck fracture: a case report.Frontiers in surgery
Understanding multiple myeloma: insights into patients' experiences and preferences for communication, information and support.Hematology (Amsterdam, Netherlands)
Pentraxin-3 dynamics and treatment response in newly diagnosed multiple myeloma.International journal of hematology
Response to Comment on: "Risk factors and their contributions to prognosis in multiple myeloma".Haematologica
Shared high-risk transcriptional programs across multiple myeloma stages associate with disease progression and poor outcome.Haematologica
ÁttekintésMultiple myeloma bone disease models with integrated bone marrow adipose tissue for advancing personalized medicine.Frontiers in oncology
Differential myeloma progression and response to TIGIT immune checkpoint blockade in Vk*MYC; NrasQ61R mice.Cancer letters
Real-world treatment patterns and clinical outcomes in relapsed/refractory multiple myeloma across Asia: a multicenter Asian Myeloma Network study (AMN010).Blood cancer journal
Flame Cells and Cohesive Plasma-Cell Clusters in IgD-Lambda Multiple Myeloma.Cytopathology : official journal of the British Society for Clinical Cytology
Szisztematikus áttekintésPredictors of cardiovascular events in multiple myeloma: a systematic review and exploratory meta-analysis.Frontiers in cardiovascular medicine
Development and multicenter validation of a predictive nomogram for infection risk in patients with multiple myeloma.Annals of hematology
Risk Stratification of Newly Diagnosed Multiple Myeloma: Predictive Value of First-Year Biomarker Trajectories Identified by Group-Based Trajectory Modeling.Cancer medicine
Cyclophosphamide maintenance in multiple myeloma without transplantation: A real-world study.Leukemia research
Disease perception, quality of life and mental health among Chinese patients with transplant-eligible newly diagnosed multiple myeloma following treatment: a cross-sectional survey study.Journal of comparative effectiveness research
EsetismertetésUnilateral Angle Closure as the Initial Presentation of Multiple Myeloma Metastasis.Journal of ophthalmic & vision research
EsetismertetésMultiple myeloma with extramedullary small bowel plasmacytoma presenting as a pyrexia of unknown origin: a case report.Journal of medical case reports
T cell redirection in high-risk smouldering multiple myeloma: can deep responses prevent progression to multiple myeloma?Nature reviews. Clinical oncology
ÁttekintésEpitranscriptomic regulation contributes to multiple myeloma biology and offers potential therapeutic targets.Neoplasia (New York, N.Y.)
Szisztematikus áttekintésPhysiological prehabilitation for patients undergoing cellular therapy in multiple myeloma and lymphoma: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Impact of socioeconomic status on treatment and survival in multiple myeloma in Australia.Blood cancer journal
Megfigyeléses vizsgálatDivergent Cost Trends for 3 Advanced Cancers, 2013 vs 2022: A Commercial Claims Analysis.The American journal of managed care
EsetismertetésMultiorgan [18F]florbetapir PET/CT uptake in multiple myeloma-associated systemic AL amyloidosis: a case report.Medical oncology (Northwood, London, England)
Spiritual beliefs and preferences among patients with multiple myeloma.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Construction and validation of a differential diagnosis model for multiple myeloma and lymphoma based on XGBoost machine learning: an explaining analysis study of SHAP.BMC medical informatics and decision making
GPRC5D-Directed Antibodies in Multiple Myeloma: New Agents and Frontline Strategies From IMS 2026.Clinical lymphoma, myeloma & leukemia
Modeling Long-Term Progression-Free Survival in Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Genomic, single-cell, and functional profiling of the CD48-CD244 axis and NK cell dysfunction in multiple myeloma.JCI insight
Sustained measurable residual disease negativity or guaranteed survival time in multiple myeloma?British journal of haematology
IL-6-driven metabolic reprogramming of the multiple myeloma microenvironment.Cancer & metabolism
Esetismertetés[Multiple myeloma with central nervous system involvement successfully treated with a multimodal therapy including elranatamab].[Rinsho ketsueki] The Japanese journal of clinical hematology
Esetismertetés[Multiple myeloma presenting with left abducens nerve palsy due to sphenoid sinus plasmacytoma].[Rinsho ketsueki] The Japanese journal of clinical hematology
PreprintGenomic characterization of patient derived xenograft models of multiple myeloma reveals selection of multiple pre-existing high risk clones.bioRxiv : the preprint server for biology
Multiple Myeloma in a Resource-Limited Setting: Clinical Presentation, Treatment Patterns, and Outcomes From a 99-Patient Cohort in Senegal.EJHaem
FcRH5-Targeted Therapy in Multiple Myeloma: Evolving Clinical Strategies and Resistance From IMS 2026.Clinical lymphoma, myeloma & leukemia
Daratumumab, Bortezomib, Lenalidomide and Dexamethasone, Upfront Autologous Transplant and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma.Transplantation and cellular therapy
Influence of CAR T-cell expansion and persistence in the peripheral blood on CAR T-cell therapy efficacy and adverse events in multiple myeloma.Bone marrow transplantation
EsetismertetésUndetected Intracellular Immunoglobulin Light Chains in Aberrant Plasma Cells of Multiple Myeloma by Monoclonal Antibody-Based Flow Cytometry: A Question Raised by a Single Case.Journal of immunology research
ÁttekintésBridging Innovation in Multiple Myeloma Care: A Review of Novel Therapies.Journal of the advanced practitioner in oncology
ÁttekintésEarly Treatment Failure in Real-World Bispecific-Antibody Therapy for Relapsed or Refractory Multiple Myeloma: Pathways, Determinants, and Measurement Gaps.OncoTargets and therapy
Prognostic significance of IgG-Kappa positivity detected by serum immunofixation during daratumumab therapy in multiple myeloma.Upsala journal of medical sciences
EsetismertetésEpithelioid Angiosarcoma Masquerading as Multiple Myeloma: A Diagnostic Pitfall.Cureus
CDK4/6i reverses MEIS2 inhibition of CRL4CRBN and promotes BCMA loss to enhance IMiD/CELMoD therapy in multiple myeloma.Blood neoplasia
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of multiple myeloma, version 2.0.Journal for immunotherapy of cancer
Orthopnea From Phrenic Nerve Palsy After Ciltacabtagene Autoleucel CAR T-Cell Therapy in a Patient With Multiple Myeloma.Journal of the advanced practitioner in oncology
Integrating biology, frailty, and patient values: The 5M framework for older adults with multiple myeloma.Clinical hematology international
PreprintComputational alternative to cardiac biopsy in multiple myeloma: utilizing the shape of routine laboratory data for the classification of AL cardiac amyloidosis.bioRxiv : the preprint server for biology
Succinate promotes multiple myeloma cell proliferation through TCA cycle oxidation.Cell reports
ÁttekintésCombination antiviral treatment for a patient with lymphocytic choriomeningitis virus meningoencephalitis associated with bispecific antibody teclistamab therapy for myeloma.The Lancet. Infectious diseases
EsetismertetésLenalidomide-associated B-cell acute lymphoblastic leukemia in a multiple myeloma patient: a case report.Journal of medical case reports
ÁttekintésPractical Recommendations for Implementing Remote Patient Monitoring for Patients Receiving Bispecific Antibodies for Multiple Myeloma.JMIR cancer
AI-Driven Structural Analysis Clarifies Novel TNFRSF17 Variants of Uncertain Significance as Candidate Resistance Mechanisms to BCMA-Targeted Immunotherapies in Multiple Myeloma.Clinical lymphoma, myeloma & leukemia
Statement of Retraction: A novel circRNA-miRNA-mRNA network revealed exosomal circ-ATP10A as a biomarker for multiple myeloma angiogenesis.Bioengineered
Esetismertetés[Personalized Dosing of Lenalidomide Based on Integrated Assessment of Renal Function and Frailty in Multiple Myeloma].Gan to kagaku ryoho. Cancer & chemotherapy
Dynamic biomarkers of kidney function in patients with newly diagnosed multiple myeloma receiving daratumumab-based combination therapy.British journal of haematology
The impact of pomalidomide-containing induction on stem cell mobilization and engraftment in multiple myeloma: a single-center experience.Annals of hematology
Machine-Learning-Guided Identification of CCT245737 as a Functional Pan-G-Quadruplex Ligand for the Treatment of Multiple Myeloma.The journal of physical chemistry. B
Increased Overall Survival for Subcutaneous Versus Intravenous Daratumumab in Medicare Beneficiaries With Multiple Myeloma.Clinical lymphoma, myeloma & leukemia
An Open-label, Multicenter, Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) in Combination with Propranolol and G-CSF for the Mobilization of Hematopoietic Progenitor Cells in Multiple Myeloma Patients.Transplantation and cellular therapy
Impact of granulocyte colony-stimulating factors on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma.Blood cancer journal
ÁttekintésBispecific antibodies targeting B-cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions.Cancer
Integration of peripheral blood lymphocyte subsets and cytokines enhances prognostic stratification in newly diagnosed multiple myeloma.British journal of haematology
EsetismertetésIntrathyroidal Relapse of Multiple Myeloma Mimicking Primary Thyroid Neoplasia: A Case Report and Literature Review.AACE endocrinology and diabetes
Bone recovery after treatment study: Evidence of myeloma bone disease repair and partial microenvironment recovery.British journal of haematology
Is Targeted Molecular Imaging of Multiple Myeloma the Future?Radiology
Publisher Correction: Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy.Nature medicine
ÁttekintésGenomics-Guided Risk Stratification in Myeloma Precursor Conditions: Converging Frameworks From Whole-Genome Sequencing.Technology in cancer research & treatment
ÁttekintésPredictors of Malnutrition in Patients With Multiple Myeloma: A Review of the Literature.Medical science monitor : international medical journal of experimental and clinical research
Whole-body low-dose computed tomography image quality and radiation dose in multiple myeloma: A comparison between 64-slice and 128-slice scanners.Journal of clinical imaging science
Oral versus intravenous melphalan for autologous stem cell transplantation conditioning in lymphoma and multiple myeloma: a retrospective cohort study.Frontiers in oncology
EsetismertetésSolitary skull lesion as the initial presentation of multiple myeloma: A case report and review of the literature.Surgical neurology international
Real-World Experience of Using Next-Generation-Sequencing in Multiple Myeloma Diagnostics in the UK National Health Service.Clinical lymphoma, myeloma & leukemia